Tirzepatide (Mounjaro) - a novel Pharmacotherapeutic Agent for Obesity

J Pak Med Assoc. 2023 May;73(5):1171. doi: 10.47391/JPMA.7685.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Gastric Inhibitory Polypeptide*
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Hypoglycemic Agents
  • Obesity / drug therapy

Substances

  • tirzepatide
  • Gastric Inhibitory Polypeptide
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor